Gene · 55
Papers3,704
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 3,704
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cancer-associated fibroblast-derived gene signatures predict radiotherapeutic survival in prostate cancer patients. | J Transl Med | 2022 | 36195908 | PubTator, text mining | PubMed |
| Adenosine signaling: Optimal target for gastric cancer immunotherapy. | Front Immunol | 2022 | 36189223 | PubTator, text mining | PubMed |
| Enamel defects in Acp4R110C/R110C mice and human ACP4 mutations. | Sci Rep | 2022 | 36183038 | PubTator, text mining | PubMed |
| Drug resistance in metastatic castration-resistant prostate cancer: an update on the status quo. | Cancer Drug Resist | 2022 | 36176747 | PubTator, text mining | PubMed |
| Study on Risk Factors of Primary Non-traumatic OVCF in Chinese Elderly and a Novel Prediction Model. | Orthop Surg | 2022 | 36168985 | PubTator, text mining | PubMed |
| Functional prediction and profiling of exosomal circRNAs derived from seminal plasma for the diagnosis and treatment of oligoasthenospermia. | Exp Ther Med | 2022 | 36168415 | PubTator, text mining | PubMed |
| The roles of small extracellular vesicles in cancer and immune regulation and translational potential in cancer therapy. | J Exp Clin Cancer Res | 2022 | 36167539 | PubTator, text mining | PubMed |
| Nanomedicine approaches for treatment of hematologic and oncologic malignancies. | World J Clin Oncol | 2022 | 36157164 | PubTator, text mining | PubMed |
| Recent findings on chimeric antigen receptor (CAR)-engineered immune cell therapy in solid tumors and hematological malignancies. | Stem Cell Res Ther | 2022 | 36153626 | PubTator, text mining | PubMed |
| Plasmid DNA for Therapeutic Applications in Cancer. | Pharmaceutics | 2022 | 36145609 | PubTator, text mining | PubMed |
| Revealing the Hidden Diagnostic Clues of Male Infertility from Human Seminal Plasma by Dispersive Solid Phase Extraction and MALDI-TOF MS. | Int J Mol Sci | 2022 | 36142695 | PubTator, text mining | PubMed |
| Boosting the Immune Response-Combining Local and Immune Therapy for Prostate Cancer Treatment. | Cells | 2022 | 36139368 | PubTator, text mining | PubMed |
| Effectiveness of Virchow's Node Fine-Needle Biopsy for the Discovery of Occult Metastatic Prostate Cancer. | Cureus | 2022 | 36106270 | PubTator, text mining | PubMed |
| Unsaturated fatty acid synthesis in Enterococcus faecalis requires a specific enoyl-ACP reductase. | Mol Microbiol | 2022 | 36100979 | PubTator, text mining | PubMed |
| Prostate Cancer Review: Genetics, Diagnosis, Treatment Options, and Alternative Approaches. | Molecules | 2022 | 36080493 | PubTator, text mining | PubMed |
| Seminal Plasma Glycoproteins as Potential Ligands of Lectins Engaged in Immunity Regulation. | Int J Environ Res Public Health | 2022 | 36078205 | PubTator, text mining | PubMed |
| Reversible epigenetic alterations regulate class I HLA loss in prostate cancer. | Commun Biol | 2022 | 36050516 | PubTator, text mining | PubMed |
| Urinary marker panels for aggressive prostate cancer detection. | Sci Rep | 2022 | 36050450 | PubTator, text mining | PubMed |
| Phase Ia/b, Open-Label, Multicenter Study of AZD4635 (an Adenosine A2A Receptor Antagonist) as Monotherapy or Combined with Durvalumab, in Patients with Solid Tumors. | Clin Cancer Res | 2022 | 36044531 | PubTator, text mining | PubMed |
| Emerging strategies in targeting tumor-resident myeloid cells for cancer immunotherapy. | J Hematol Oncol | 2022 | 36031601 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/55/papers?page=15